Adagio Therapeutics, Inc. ADGI
4.64 +4.64
Day range unavailable
52-week range unavailable
News
globenewswire.com Adagio Therapeutics to Participate in Upcoming Investor Conferences WALTHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of…
247wallst.com Hedge Fund M28 Capital Increases Adagio Therapeutics (ADGI) Stake to 8.5% Last Friday, health care focused hedge fund M28 Capital filed a 13D/A with the US Securities & Exchange Committee revealing it bought 2.85 million Adagio Therapeutics (US:ADGI) at an average of $4.28…
benzinga.com Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments…
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 721 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 431 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 242 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 466 companies hit new 52-week lows.
zacks.com Adagio's (ADGI) COVID-19 Antibody Meets Goals in Studies The stock price of Adagio (ADGI) surge after it reports positive preliminary data from the phase II/III studies, which evaluate its monoclonal antibody for the prevention and treatment of COVID-19.
investorplace.com Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today? Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV,…
benzinga.com Adagio's COVID-19 Antibody Meets Primary Goals Across Pre & Post-Exposure Prophylaxis, Treatment Adagio Therapeutics Inc's (NASDAQ: ADGI) Phase 2/3 trials evaluating 300 mg adintrevimab (ADG20) as pre-and-post-exposure prophylaxis (EVADE) and treatment (STAMP) for COVID-19 have met its primary…
fool.com Why Adagio Therapeutics Stock Is Soaring Today Investors are reacting to better than expected clinical trial results for its COVID-19 treatment candidate.- benzinga.com Why Adagio Therapeutics Stock Is Soaring Today Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the first monoclonal antibody to meet primary…
barrons.com Adagio Stock Spikes on New Data, but Its Omicron Problems Remain Adagio Therapeutics says it will seek an emergency use authorization for its Covid-19 antibody, known as ADG20, in the second quarter.
pennystocks.com Trading Penny Stocks? Top Stock Market News for March 30th, 2022 Here's what you need to know about trading penny stocks on March 30th The post Trading Penny Stocks? Top Stock Market News for March 30th, 2022 appeared first on Penny Stocks to Buy, Picks, News and…- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 166 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 112 stocks made new 52-week lows.
gurufocus.com 2 Net Current Asset Value Stocks to Consider There are some investors who buy U.S.-listed stocks that are trading below their liquidation value because they believe there is a lot to gain in these stocks after the market reprices shares to near…
benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 39 stocks hit new 52-week lows.
seekingalpha.com Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention Three recent independent in-vitro studies show that ADG20 has neutralization activity against Omicron.- benzinga.com 60 Biggest Movers From Yesterday Gainers US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash.
marketwatch.com 12 biotech stocks to consider buying now as prospects for the sector brighten this year Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double
investopedia.com Top 5 IPOs of 2021 Digital World Acquisition, ZIM Integrated Shipping Services, Adagio Therapeutics, Roblox, and Doximity saw the largest percentage increase in stock price since initial listing.
fool.com Why Shares of Adagio Therapeutics Soared 25.9% on Thursday The clinical-stage biotech company is working on an antiviral treatment to fight multiple variants of COVID-19.- benzinga.com 52 Biggest Movers From Friday Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its TapouT performance…
stockmarket.com 5 Top Biotech Stocks To Watch In January 2022 Could these biotech stocks be poised for gains in 2022?- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.
pulse2.com Adagio Therapeutics Stock (ADGI): Why The Price Went Up Today The stock price of Adagio Therapeutics Inc (NASDAQ: ADGI) increased by over 16% during intraday trading today. This is why it happened.
globenewswire.com Adagio Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference WALTHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of…- benzinga.com 50 Biggest Movers From Yesterday Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday.
fool.com Why Adagio Therapeutics Stock Dived by 13% Today Another analyst gets notably less bullish on the company's prospects.
benzinga.com 58 Biggest Movers From Yesterday Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
pulse2.com Adagio Therapeutics Stock (ADGI): Why The Price Surged Over 120% Today The stock price of Adagio Therapeutics Inc (NASDAQ: ADGI) increased by over 120% today. This is why it happened.
investorplace.com ADGI Stock Alert: 4 Things to Know as Adagio Therapeutics Rockets 100% Shares of ADGI stock have more than doubled today. With no direct news, investors are curious to know what is driving the price momentum.- benzinga.com 46 Biggest Movers From Yesterday Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
- benzinga.com 54 Biggest Movers From Yesterday Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
- benzinga.com 92 Biggest Movers From Friday Gainers
- benzinga.com 64 Stocks Moving In Friday's Mid-Day Session Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range…
- benzinga.com 53 Biggest Movers From Yesterday Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.
- benzinga.com 46 Biggest Movers From Yesterday Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.
- benzinga.com 72 Biggest Movers From Yesterday Gainers
- benzinga.com 60 Biggest Movers From Friday Gainers
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021 Upgrades
- benzinga.com 78 Biggest Movers From Friday Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.